Titan Biotech Limited (BOM:524717)
383.20
-8.30 (-2.12%)
At close: Oct 5, 2026
Titan Biotech Revenue
Titan Biotech had revenue of 591.67M INR in the quarter ending June 30, 2026, with 27.25% growth. This brings the company's revenue in the last twelve months to 2.19B, up 36.93% year-over-year. In the fiscal year ending March 31, 2026, Titan Biotech had annual revenue of 2.06B with 31.79% growth.
Revenue (ttm)
2.19B
Revenue Growth
+36.93%
P/S Ratio
7.23
Revenue / Employee
4.15M
Employees
527
Market Cap
15.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.06B | 497.40M | 31.79% |
| Mar 31, 2025 | 1.56B | -76.21M | -4.65% |
| Mar 31, 2024 | 1.64B | 200.73M | 13.94% |
| Mar 31, 2023 | 1.44B | 204.50M | 16.55% |
| Mar 31, 2022 | 1.24B | -186.92M | -13.14% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rico Auto Industries | 26.89B |
| Goodyear India | 25.94B |
| Insecticides (India) | 20.69B |
| DISA India | 4.25B |
| Menon Bearings | 3.19B |
| Wendt (India) | 2.55B |
| Paushak | 2.46B |
| Investment & Precision Castings | 1.98B |